Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL952786

O=C(NC1CCNC1)OCc1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
GAA P10253 1/20 0.55
TSHR P16473 1/20 0.53
EPHX1 P07099 1/20 0.50
ITGB3 P05106 2/20 0.48
ITGA2B P08514 2/20 0.48
CTSL P07711 2/20 0.48
CTSB P07858 1/20 0.48
CTSK P43235 1/20 0.48
ITGAV P06756 1/20 0.48
CPB1 P15086 1/20 0.46
TACR1 P25103 2/20 0.45
DPP4 P27487 2/20 0.45
DPP7 Q9UHL4 2/20 0.45
TLR4 O00206 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2901586 0.93 ALDH1A1 (0.63) ALDH1A1GAATSHREPHX1CTSL
SCHEMBL240039 0.93 ALDH1A1 (0.63) ALDH1A1GAATSHREPHX1CTSL
SCHEMBL240038 0.93 ALDH1A1 (0.63) ALDH1A1GAATSHREPHX1CTSL
Hydrochloric Acid SCHEMBL2854037 0.91 ALDH1A1 (0.61) ALDH1A1GAATSHREPHX1CTSL
Hydrochloric Acid SCHEMBL243635 0.91 ALDH1A1 (0.61) ALDH1A1GAATSHREPHX1CTSL
Hydrochloric Acid SCHEMBL243634 0.91 ALDH1A1 (0.61) ALDH1A1GAATSHREPHX1CTSL
Trifluoroacetic Acid SCHEMBL3331266 0.90 ALDH1A1 (0.56) ALDH1A1GAATSHREPHX1CTSL
Trifluoroacetic Acid SCHEMBL8439864 0.86 EPHX1 (0.46) ALDH1A1GAATSHREPHX1ITGB3
Trifluoroacetic Acid SCHEMBL8438721 0.86 EPHX1 (0.46) ALDH1A1GAATSHREPHX1ITGB3
SCHEMBL31285963 0.86 ALDH1A1 (0.58) ALDH1A1GAATSHREPHX1ITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115666553-A TLR2 modulator compounds, and pharmaceutical compositions and uses thereof 轴向治疗公司 2023-01-31 CN disclosed
US-8426420-B2 Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists SANOFI (FR) 2013-04-23 US disclosed
EP-2238128-B1 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS SANOFI SA (FR) 2012-08-22 EP disclosed
US-20110021537-A1 HETEROCYCLIC PYRAZOLE-CARBOXAMIDESAS P2Y12 ANTAGONISTS SANOFI-AVENTIS (FR) 2011-01-27 US disclosed
EP-2238128-A2 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS Sanofi-Aventis (FR) 2010-10-13 EP disclosed
WO-2009080226-A2 HETEROCYCLIC PYRAZOLE-CARBOXAMIDES AS P2Y12 ANTAGONISTS SANOFIS-AVENTIS (FR) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021537-A1 HETEROCYCLIC PYRAZOLE-CARBOXAMIDESAS P2Y12 ANTAGONISTS P2RY1, P2RY12, P2RY11 ALDH1A1 1179/4885GAA 1779/4885TSHR 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.